# Telemetría de Benchmark: Bonsai-27B

| Caso de Prueba | Condición | Tiempo Total (s) | Tokens Generados | Velocidad (tokens/s) |
| :--- | :---: | :---: | :---: | :---: |
| CASO_1_EXPANSION | SIN RAG | 31.09s | 1000 | **32.17 t/s** |
| CASO_1_EXPANSION | CON RAG | 32.88s | 1000 | **30.42 t/s** |
| CASO_2_REGRESION | SIN RAG | 32.51s | 1000 | **30.76 t/s** |
| CASO_2_REGRESION | CON RAG | 33.51s | 1000 | **29.84 t/s** |
| CASO_3_ESTABILIDAD | SIN RAG | 33.75s | 1000 | **29.63 t/s** |
| CASO_3_ESTABILIDAD | CON RAG | 33.71s | 1000 | **29.67 t/s** |


## Detalle de Diagnósticos Generados

### [SIN RAG] CASO_1_EXPANSION
**Latencia:** 31.09s | **Velocidad:** 32.17 t/s

Here's a thinking process:

1.  **Analyze User Input:**
   - **Role:** Expert quantitative dermatology clinical assistant
   - **Task:** Analyze evolution between two dermatological photographic controls
   - **Metrics Provided:**
     - Area Variation: +33.33% (4200 px → 5600 px)
     - Circularity Variation: -0.19 (0.81 → 0.62)
   - **Instructions:**
     1. Technically conclude morphometric evolution
     2. Issue a medical behavior recommendation based on available clinical guidelines

2.  **Deconstruct Metrics & Clinical Meaning:**
   - *Area Variation (+33.33%):* Significant increase in lesion size (area). In dermatology, this typically indicates progression of inflammation, tumor growth, or wound expansion. Could be benign (e.g., viral eruption, eczema flare) or malignant depending on context.
   - *Circularity (-0.19 from 0.81 to 0.62):* Decrease in circularity means the lesion is becoming less round/more irregular/elongated. Normal skin lesions are often more circular; a drop suggests irregular borders, possible malignancy (though not definitive alone), or inflammatory changes with irregular margins.
   - *Combined Interpretation:* Enlargement + loss of symmetry/circularity = morphometric progression toward irregularity. This pattern warrants clinical correlation and possibly biopsy if malignant features are suspected.

3.  **Technical Conclusion (Morphometric Evolution):**
   - Need to state clearly: The lesion has undergone significant enlargement (+33.3%) and a marked reduction in circularity (-0.19), indicating a shift from a relatively symmetric, compact morphology to an irregular, expanded shape. This morphometric progression suggests active disease process, possibly inflammatory or neoplastic, requiring clinical correlation with histopathology and full dermatoscopic/clinical assessment.

4.  **Medical Recommendation (Clinical Guidelines):**
   - Need to reference standard dermatological guidelines (e.g., AAD, EADV, WHO/IARC for melanoma, general lesion evaluation protocols).
   - Key principles: 
     - Any lesion with significant growth + irregularity warrants clinical re-evaluation.
     - Use of dermatoscopy, ABCDE criteria (for melanoma), or other classification systems.
     - If malignant features suspected → biopsy.
     - If benign/inflammatory → treat underlying cause, monitor.
     - Emphasize that quantitative metrics alone don't diagnose; they're adjunctive tools.
   - Structure recommendation: 
     - Immediate clinical assessment (dermatoscopy, full exam)
     - Correlate with symptoms/history
     - Follow guideline-based algorithm (e.g., AAD/ISD guidelines for lesion evaluation)
     - If high suspicion → biopsy + histopathology
     - Patient education & follow-up schedule
     - Note limitations of quantitative metrics

5.  **Draft Response (Mental Refinement in Spanish):**
   *(Structure)*
   - Conclusión técnica de evolución morfométrica
   - Recomendación médica basada en guías clínicas
   - Aclaraciones importantes (límites, necesidad de correlación clínica)
   
   *(Content - Spanish)*
   **1. Conclusión Técnica de Evolución Morfométrica:**
   La comparación cuantitativa revela una expansión significativa del área lesionada (+33,33%, de 4200 a 5600 px), lo que indica un crecimiento activo o expansión inflamatoria. Paralelamente, la circularidad disminuyó en un 19% (de 0,81 a 0,62), reflejando una pérdida de simetría y un aumento de irregularidad perimétrica. En términos morfométricos, esto corresponde a una transición de una lesión compacta y relativamente circunscrita hacia una forma más irregular y asimétrica. Esta combinación de crecimiento + reducción de circularidad es un patrón morfométrico de progresión que, en dermatología cuantitativa, se asocia con procesos inflamatorios agudos, cambios neoplásticos o evolución de lesiones crónicas, requiriendo correlación obligatoria con la evaluación clínica completa y, cuando sea necesario, histopatología.

   **2. Recomendación Médica Basada en Guías Clínicas:**
   Según las directrices actuales de dermatología (AAD, EADV, ISD y criterios ABCDE para melanoma), se recomienda:
   - **Evaluación clínica inmediata:** Revisión completa del paciente, incluyendo dermatoscopía sistemática. La reducción de circularidad + crecimiento >20-30

---

### [CON RAG] CASO_1_EXPANSION
**Latencia:** 32.88s | **Velocidad:** 30.42 t/s

Here's a thinking process:

1.  **Analyze User Input:**
   - **Role:** Expert clinical dermatologist specializing in quantitative dermatology.
   - **Task:** Analyze the evolution between two dermatological photographic controls.
   - **Quantitative Metrics:**
     - Area variation: +33.33% (4200 px -> 5600 px)
     - Circularity variation: -0.19 (0.81 -> 0.62)
   - **Clinical Literature (RAG):**
     - *Morphometric Criterion:* Decrease in circularity index (< -0.08 or absolute < 0.60) reflects loss of surface tension, irregular borders, scarring, or asymmetric radial growth → structural atypia criterion.
     - *Clinical Guideline (guía.pdf):* Prognosis for local-regional involvement is an active study area. If Breslow index > 0.5 mm, risk of potential dissemination increases → requires comprehensive management via oncology committee with multidisciplinary team.
   - **Instructions:**
     1. Conclude technically on the morphometric evolution.
     2. Emit a medical behavior recommendation based on available clinical guidelines.

2.  **Deconstruct & Interpret Metrics:**
   - *Area Increase (+33.33%):* Significant lesion expansion. In dermatology, especially melanoma/suspected malignant lesions, rapid or substantial growth is a red flag (one of the "Islands" in ABCDEs: B for Border, but also D for Diameter/Size change).
   - *Circularity Decrease (-0.19, from 0.81 to 0.62):* 
     - Absolute value dropped below 0.70 (close to threshold) and the delta is -0.19, which is well below the clinical threshold of < -0.08 mentioned in the literature.
     - This indicates loss of symmetry/roundness, irregular borders, possible scarring or asymmetric growth → matches "criterio de atipia estructural" (structural atypia criterion).
   - *Combined:* The lesion is growing significantly and becoming more irregular/asymmetric. This strongly suggests malignant transformation or aggressive benign progression.

3.  **Synthesize Technical Conclusion (Instruction 1):**
   - Need to state clearly: The quantitative analysis reveals a significant morphometric evolution characterized by a 33.33% increase in lesion area and a marked decrease in circularity (-0.19, absolute value 0.62). This pattern meets the clinical threshold for structural atypia (Δcircularidad < -0.08 y valor absoluto ≤ 0.70), indicating loss of surface tension, irregular border morphology, and asymmetric radial growth. The evolution is consistent with a prograde morphological change requiring further evaluation.

4.  **Formulate Clinical Recommendation (Instruction 2):**
   - Based on guidelines: 
     - Significant growth + structural atypia → high suspicion for melanoma or aggressive lesion.
     - Need to assess Breslow depth (though not provided, the guideline mentions it as a critical factor).
     - If Breslow > 0.5 mm → multidisciplinary oncology committee referral.
     - Even without Breslow data, the morphometric changes warrant urgent dermatological evaluation, biopsy if not done, staging, and possibly referral to melanoma specialist/oncology.
   - Structure recommendation: 
     - Immediate clinical correlation with physical exam (ABCDEs).
     - Confirm/obtain histopathological diagnosis (biopsy) if not already done.
     - Assess Breslow depth and tumor stage.
     - If Breslow > 0.5 mm or high-risk features present → refer to multidisciplinary melanoma/oncology committee for comprehensive management (surgical, adjuvant therapy, follow-up).
     - Emphasize urgency due to quantitative morphometric red flags.

5.  **Draft Response (Mental Refinement in Spanish):**
   *(Structure according to instructions)*
   **1. Conclusión técnica sobre la evolución morfométrica:**
   La comparación cuantitativa entre los dos controles revela una evolución progresiva y alarmante: un aumento del 33,33 % en el área de la lesión (de 4200 a 5600 px) y una disminución marcada de su índice de circularidad (-0,19, pasando de 0,81 a 0,62). Este patrón cuantitativo cumple con los umbrales clínicos establecidos para atipia estructural (Δcircularidad < -0,08 y valor

---

### [SIN RAG] CASO_2_REGRESION
**Latencia:** 32.51s | **Velocidad:** 30.76 t/s

Here's a thinking process:

1.  **Analyze User Input:**
   - **Role:** Expert clinical dermatologist specializing in quantitative dermatology.
   - **Task:** Analyze the morphometric evolution between two photographic controls.
   - **Metrics Provided:**
     - Area Variation: -100% (Control 1: 3150.0 px -> Control 2: 0.0 px)
     - Circularity Variation: -0.77 (Control 1: 0.77 -> Control 2: 0.0)
   - **Instructions:**
     1. Technically conclude the morphometric evolution.
     2. Issue a medical conduct recommendation based on available clinical guidelines.

2.  **Deconstruct the Metrics:**
   - *Area Variation:* -100% means the lesion/area went from 3150 px² to 0 px². This indicates complete disappearance or resolution of the measured area.
   - *Circularity Variation:* Circularity is typically calculated as (4πA) / P², where A is area and P is perimeter. Values range from 0 (line/fragmented) to 1 (perfect circle). Here, it went from 0.77 (moderately circular) to 0.0 (completely non-circular, likely fragmented, linear, or completely absent).
   - *Combined Interpretation:* The lesion has completely resolved/disappeared. The drop in circularity to 0.0 is mathematically expected when area goes to 0, but it also suggests that if any residual structure existed, it would be highly irregular/fragmented. However, given the -100% area change, the most logical conclusion is complete resolution.

3.  **Technical Conclusion (Morphometric Evolution):**
   - Need to state clearly: Complete resolution/disappearance of the lesion.
   - Explain the metrics: Area reduction of 100% indicates total loss of measurable tissue/lesion. Circularity dropping to 0.0 is a mathematical consequence of zero area but also confirms no residual irregular structure remains.
   - Use precise dermatological terminology: "Resolución completa", "disparición total de la lesión medible", "cambio morfométrico irreversible en el contexto del control".

4.  **Medical Recommendation (Clinical Guidelines):**
   - Need to base this on standard dermatological guidelines for lesion resolution monitoring.
   - Key points:
     - Document the complete resolution.
     - Recommend follow-up imaging if there's any clinical suspicion of recurrence, atypical presentation, or underlying condition requiring long-term monitoring.
     - Advise against unnecessary interventions given full resolution.
     - Mention standard guidelines (e.g., AAD, EADV, dermatological imaging standards) emphasize documenting resolution but maintaining clinical vigilance for atypical lesions.
     - Recommend continuing routine surveillance if the lesion was malignant or high-risk, otherwise discontinue targeted monitoring.
   - Structure: Clear, guideline-based recommendation covering documentation, follow-up strategy, and patient counseling.

5.  **Draft Response (Mental Refinement):**
   *(Technical Conclusion)*
   La evolución morfométrica entre los dos controles fotográficos demuestra una resolución completa de la lesión dermatológica. La variación del -100% en el área indica que la superficie medible ha desaparecido por completo (de 3150 px² a 0 px²). La caída de la circularidad desde 0.77 hasta 0.0 es una consecuencia matemática directa de la nulaificación del área, pero también confirma la ausencia de cualquier estructura residual irregular o fragmentada. En términos clínicos, esto corresponde a una resolución total y estable de la lesión evaluada.

   *(Medical Recommendation)*
   Según las guías clínicas actuales de dermatología cuantitativa e imagen médica (AAD, EADV, y estándares de seguimiento de lesiones cutáneas):
   1. **Documentación:** Registrar formalmente la resolución completa en el historial clínico y en el sistema de seguimiento fotográfico.
   2. **Seguimiento:** Si la lesión original presentaba características sospechosas de malignidad o alta riesgo, mantener un protocolo de vigilancia periódica (cada 3-6 meses) con evaluación clínica y, si es necesario, biopsia o imagen avanzada, hasta que se confirme estabilidad a largo plazo (>2 años). Si fue benigna o de origen inflamatorio/infecioso resuelto, puede suspenderse el seguimiento dirigido.
   3. **Consejo al paciente:** Informar sobre la resolución exitosa y reforzar la importancia de la detección temprana de recurrencias

---

### [CON RAG] CASO_2_REGRESION
**Latencia:** 33.51s | **Velocidad:** 29.84 t/s

Here's a thinking process:

1.  **Analyze User Input:**
   - **Role:** Expert quantitative dermatology clinical assistant.
   - **Task:** Analyze the evolution between two dermatological photographic controls.
   - **Quantitative Metrics:**
     - Area Variation: -100% (Control 1: 3150.0 px -> Control 2: 0.0 px)
     - Circularity Variation: -0.77 (Control 1: 0.77 -> Control 2: 0.0)
   - **Clinical Literature (RAG):**
     - *Morphometric Criterion:* Decrease in circularity index (< -0.08 or absolute < 0.60) reflects loss of surface tension, irregular borders, scarring, or asymmetric radial growth -> structural atypia criterion.
     - *guidance.pdf:* Prognosis for locoregional commitment is an active research area (see section III.c.2). If Breslow index > 0.5mm, risk of potential dissemination increases, requiring integral management through a multidisciplinary oncology committee.
   - **Instructions:**
     1. Conclude technically on the morphometric evolution.
     2. Issue a medical behavior recommendation based on available clinical guidelines.

2.  **Deconstruct Quantitative Metrics:**
   - *Area Variation:* -100% (3150 -> 0 px). This is mathematically impossible in real imaging unless it means the lesion completely disappeared, was excised, or the segmentation failed entirely. In a clinical context, this likely indicates either:
     a) Complete resolution/excision of the lesion.
     b) Segmentation error (algorithm couldn't detect any pixels in Control 2).
     c) The lesion vanished due to treatment.
     I need to address this carefully. A -100% area change is extreme and requires clinical correlation. It could mean complete regression, but also could be an artifact. I'll note the mathematical implication and suggest verification of segmentation/clinical context.
   - *Circularity Variation:* -0.77 (0.77 -> 0.0). This indicates a drastic loss of circular shape, becoming highly irregular or non-existent. Circularity = 4π*Area/Perimeter². A value of 1 is perfect circle, 0 is degenerate/non-circular. The drop to 0.0 suggests either complete disappearance (matching the area) or severe morphological distortion/scarring if it persisted. Given the area also went to 0, both metrics likely reflect lesion elimination or segmentation failure.

3.  **Cross-Reference with Clinical Literature:**
   - *Morphometric Criterion:* Decrease in circularity < -0.08 or absolute < 0.60 indicates structural atypia (loss of surface tension, irregular borders, scarring, asymmetric growth). Here, the change is -0.77 and absolute is 0.0, which far exceeds the threshold for atypia *if* the lesion were still present. However, since area is also 0, this criterion might not apply directly to a remaining lesion. I should clarify that if the lesion persisted, it would represent extreme structural atypia. If it disappeared, the metric reflects resolution/excision.
   - *Guidance:* Mentions Breslow index > 0.5mm increases dissemination risk, requiring multidisciplinary oncology committee. This is relevant for melanoma or other skin cancers where depth matters. The quantitative data doesn't provide Breslow depth, but I should integrate this guideline into the recommendation.

4.  **Formulate Technical Conclusion (Instruction 1):**
   - Acknowledge the metrics: Area dropped to 0 px (-100%), circularity dropped to 0.0 (-0.77).
   - Interpret: Mathematically, this indicates complete disappearance of the segmented lesion or a critical segmentation failure in Control 2. If clinically verified as resolution/excision, it represents successful treatment or spontaneous regression. If the lesion persisted but was missegmented, the circularity drop would indicate extreme morphological atypia (border irregularity, loss of symmetry), exceeding structural atypia thresholds (<0.60 absolute).
   - Emphasize need for clinical correlation and image verification to rule out algorithmic artifact vs. true biological change.

5.  **Formulate Medical Recommendation (Instruction 2):**
   - Based on guidelines: If the lesion disappeared, confirm with histopathology if excised, monitor for recurrence. If it persisted but metrics suggest atypia, given the extreme morphometric changes and potential structural irregularity, a biopsy is indicated.
   - Integrate Bres

---

### [SIN RAG] CASO_3_ESTABILIDAD
**Latencia:** 33.75s | **Velocidad:** 29.63 t/s

Here's a thinking process:

1.  **Analyze User Input:**
   - **Role:** Expert clinical dermatologist specializing in quantitative dermatology.
   - **Task:** Analyze the morphometric evolution between two photographic controls.
   - **Metrics Provided:**
     - Area Variation: +1.79% (Control 1: 2800.0 px -> Control 2: 2850.0 px)
     - Circularity Variation: -0.01 (Control 1: 0.84 -> Control 2: 0.83)
   - **Instructions:**
     1. Conclude technically on morphometric evolution.
     2. Issue a medical management recommendation based on available clinical guidelines.

2.  **Deconstruct the Metrics & Context:**
   - *Area Variation (+1.79%):* Indicates a slight increase in lesion size over time. In dermatology, this could suggest progression (e.g., inflammatory phase of psoriasis, expanding melanoma, growing benign lesion) or regression (if negative), but here it's positive growth. 1.79% is relatively small but clinically relevant depending on the lesion type and baseline.
   - *Circularity (-0.01):* Circularity index = π × (4A/P²). Values range from 0 to 1, with 1 being a perfect circle. A decrease from 0.84 to 0.83 indicates a slight loss of symmetry/regularity, becoming more irregular or elongated. In dermatology, increased irregularity is often a red flag for malignancy (e.g., melanoma) but can also occur in inflammatory conditions.
   - *Combined Interpretation:* Slight enlargement + slight loss of circularity/symmetry. This pattern warrants clinical correlation. It's not dramatic, but it suggests morphometric changes that may indicate early progression or altered lesion characteristics.

3.  **Technical Conclusion (Instruction 1):**
   - Need to state clearly: The lesion shows a modest increase in area (+1.79%) and a slight decrease in circularity (-0.01), indicating a trend toward enlargement and increased morphological irregularity.
   - Emphasize that these changes are within the range of measurement variability but represent a detectable shift requiring clinical correlation.
   - Note that without lesion type, patient history, imaging, or biopsy results, definitive diagnosis cannot be made. However, the pattern (enlargement + loss of symmetry) aligns with early morphometric progression seen in inflammatory or neoplastic conditions.

4.  **Medical Recommendation (Instruction 2):**
   - Must align with dermatology guidelines (e.g., AAD, EADV, WHO/IARC for melanoma, psoriasis guidelines).
   - Key principles: 
     - Monitor closely if benign/inflammatory.
     - If malignant suspected, urgent biopsy/dermatoscopy.
     - Consider clinical context: lesion type, patient age, sun exposure, history of changes.
     - Recommend follow-up interval (e.g., 3-6 months for stable lesions, sooner if changing).
     - Emphasize need for in-person evaluation with dermatoscopy and possibly biopsy.
   - Structure recommendation: 
     - Immediate action based on clinical suspicion.
     - Follow-up protocol.
     - Adjunctive tests (dermatoscopy, biopsy, imaging if indicated).
     - Patient education/counseling.

5.  **Draft Response (Mental Refinement):**
   *(Technical Conclusion)*
   La evolución morfométrica entre los dos controles fotográficos revela un aumento moderado en el área de la lesión (+1.79%, de 2800 a 2850 px) y una leve disminución en su circularidad (-0.01, de 0.84 a 0.83). Este patrón indica un crecimiento dimensional detectable acompañado por una pérdida progresiva de simetría y regularidad periférica. Aunque las magnitudes son pequeñas, representan cambios estadísticamente significativos en análisis cuantitativos dermatológicos y sugieren una evolución dinámica que puede corresponder a fase inflamatoria temprana, expansión benigna o, en casos sospechosos, progresión neoplástica incipiente. La interpretación definitiva requiere correlación clínica con el tipo de lesión, historia del paciente, exposición solar y evaluación dermatoscópica.

   *(Medical Recommendation)*
   Según las guías clínicas actuales (AAD, EADV, IARC/WHO), se recomienda:
   1. **Evaluación clínica inmediata** por parte de un dermatólogo para correlacionar los cambios fotométricos con el aspecto macroscóp

---

### [CON RAG] CASO_3_ESTABILIDAD
**Latencia:** 33.71s | **Velocidad:** 29.67 t/s

Here's a thinking process:

1.  **Analyze User Input:**
   - **Role:** Expert clinical assistant in quantitative dermatology.
   - **Task:** Analyze the evolution between two dermatological photographic controls.
   - **Quantitative Metrics:**
     - Area Variation: +1.79% (2800.0 px -> 2850.0 px)
     - Circularity Variation: -0.01 (0.84 -> 0.83)
   - **Clinical Literature (RAG):**
     - *Morphometric Criterion:* Decrease in circularity index (< -0.08 or absolute < 0.60) reflects loss of surface tension, irregular borders, scarring, or asymmetric radial growth → structural atypia criterion.
     - *Clinical Guideline (guía.pdf):* Prognosis for locoregional commitment is an active research area (see section III.c.2). If Breslow index > 0.5 mm, risk of potential dissemination increases, requiring integral management through a multidisciplinary oncology committee.
   - **Instructions:**
     1. Conclude technically on the morphometric evolution.
     2. Issue a medical behavior recommendation based on available clinical guidelines.

2.  **Deconstruct & Evaluate Metrics vs. Criteria:**
   - *Area Variation:* +1.79% (increase from 2800 to 2850 px). This is a modest increase (~1.8%). In dermatology, lesion growth can be benign or malignant, but alone it's not highly specific. However, combined with other factors, it needs context.
   - *Circularity Variation:* -0.01 (from 0.84 to 0.83). This is a very small decrease. The criterion for structural atypia specifies delta < -0.08 or absolute circularity < 0.60. Here, delta = -0.01 and absolute = 0.83, both well above the threshold for concern. So, morphometrically, it does *not* meet the criteria for structural atypia based on this specific guideline.
   - *Overall Morphometric Evolution:* Minimal change in area (+1.79%) and negligible decrease in circularity (-0.01). The lesion maintains a high degree of circularity (0.83), indicating preserved symmetry and regular border morphology. No clear morphometric red flags for malignancy or structural atypia based on these metrics alone.

3.  **Synthesize Technical Conclusion (Instruction 1):**
   - State the quantitative changes clearly.
   - Compare against the provided morphometric criterion thresholds.
   - Conclude that the evolution is stable/minimal, with no evidence of structural atypia or significant loss of symmetry/border regularity according to the specified metric. The lesion appears morphometrically stable within normal limits for surveillance.

4.  **Formulate Medical Recommendation (Instruction 2):**
   - Reference the clinical guideline: Prognosis for locoregional commitment is under study; Breslow > 0.5 mm increases dissemination risk and requires multidisciplinary oncology committee management.
   - Note that the provided metrics don't include Breslow depth, but the recommendation should be conditional/general based on standard dermatological practice and the guideline's emphasis.
   - Since morphometric changes are minimal and no high-risk features (like Breslow > 0.5 mm or structural atypia) are indicated by the data, recommend:
     - Continue routine surveillance with defined intervals (e.g., every 3-6 months depending on risk).
     - If clinical examination reveals Breslow depth ≥ 0.5 mm, irregular borders, asymmetry, color variation, or rapid growth, escalate to multidisciplinary oncology committee evaluation and consider biopsy/surgical excision per guidelines.
     - Emphasize that quantitative metrics alone don't replace clinical assessment; integrate with visual inspection, dermatoscopy, and histopathology if indicated.
   - Structure the recommendation clearly: monitoring plan, escalation criteria, interdisciplinary approach.

5.  **Draft Response (Mental Refinement - Spanish):**
   *(Structure)*
   - Conclusión técnica de la evolución morfométrica
   - Recomendación de conducta médica
   - Base científica/guías citadas
   - Limitaciones/contexto clínico

   *(Content - Spanish)*
   **1. Conclusión técnica sobre la evolución morfométrica:**
   La comparación cuantitativa entre los dos controles muestra una variación de área del +1,79% (2800 → 2850 px) y un descenso marginal en el índice de

---

